Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Goldberg Mark Alan Create: Alert

All | News | Filings
Date FiledTypeDescription
04/20/2022 4/A Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 3,545 restricted stock units @ $0
01/11/2012 4/A Goldberg Mark Alan (SVP, Product Dvp) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 15,000 options to buy @ $23, valued at $345k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy